15 years of revenue, profit, cash flow and balance-sheet history through FY2025,
from SEC filings — with a computed, factual read of the trend.
Updated Overview →
Growth & profitability
Revenue has declined 21.3% per year over the past 5 years.
Financial health
Total debt ($93M) exceeds cash ($30M); net debt is $63M.
Total debt has grown faster than revenue (-11.5% vs -21.3% per year).
Operating income covered interest expense -28.6× in the latest year.
The company is unprofitable and has less than a year of cash runway at its current free-cash-flow burn.
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Return on equity & assets (ROE / ROA)
ROEROA
Free cash flow (CFO − capex)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key annual figures
FY
Revenue
Net income
Gross M
Op M
ROE
ROA
FCF
Total debt
Cash
2025
$10M
-$251M
0.0%
-1141.1%
-1198.4%
-161.2%
-$90M
$93M
$30M
2024
$4M
-$126M
0.0%
-3440.2%
-327.7%
-86.9%
-$77M
$0
$30M
2023
$6M
-$96M
0.0%
-1602.5%
-80.9%
-63.5%
-$68M
—
$8M
2022
$27M
$28M
0.0%
0.0%
22.4%
13.1%
-$70M
$86M
$5M
2021
$14M
-$92M
0.0%
0.0%
-85.9%
-25.6%
-$63M
$180M
$36M
2020
$32M
-$171M
0.0%
0.0%
-253.8%
-54.2%
-$85M
$172M
$52M
2019
$91M
-$322M
0.0%
0.0%
-449.5%
-70.7%
-$174M
$218M
$66M
2018
$151M
-$509M
0.0%
-334.4%
-140.4%
-71.1%
-$166M
$212M
$97M
2017
$219M
-$117M
84.8%
-62.8%
-21.9%
-13.8%
-$150M
$8M
$68M
2016
$191M
-$187M
80.2%
-65.6%
-33.3%
-19.7%
-$81M
$8M
$63M
2015
—
-$84M
—
—
-12.2%
-8.6%
$23M
$9M
$136M
2014
—
-$82M
—
—
-21.3%
-14.2%
-$26M
$10M
$27M
2013
—
-$39M
—
—
-10.6%
-8.3%
-$55M
$2M
$50M
2012
—
-$82M
—
—
25.5%
-54.0%
-$69M
—
$10M
2011
—
-$85M
—
—
—
—
-$95M
—
$20M
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Return on equity & assets (ROE / ROA)
ROEROA
Free cash flow (CFO − capex, quarterly)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key quarterly figures
Quarter
Revenue
Net income
Gross M
Op M
ROE
ROA
FCF
Total debt
Cash
Jun '26
$55M
$20M
0.0%
41.2%
46.1%
11.8%
-$18M
$94M
$16M
Mar '26
$23M
-$8M
0.0%
-25.8%
-39.2%
-5.7%
-$44M
$94M
$7M
Dec '25
—
-$24M
—
—
-112.4%
-15.1%
-$23M
$93M
$30M
Sep '25
—
-$146M
—
—
-349.5%
-85.4%
-$29M
$93M
$14M
Jun '25
$856000
-$27M
0.0%
-3710.7%
72.4%
-26.1%
-$20M
—
$14M
Mar '25
$1M
-$54M
0.0%
-1685.0%
385.2%
-42.0%
-$17M
—
$6M
Dec '24
—
-$20M
—
—
-51.2%
-13.6%
-$9M
$0
$30M
Sep '24
—
-$24M
—
—
-43.3%
-28.7%
-$24M
—
$25M
Jun '24
—
-$59M
—
—
-136.2%
-80.4%
-$25M
—
$9M
Mar '24
—
-$24M
—
—
-24.5%
-17.6%
-$18M
—
$17M
Dec '23
—
-$33M
—
—
-27.9%
-21.9%
-$17M
—
$8M
Sep '23
—
-$20M
—
—
-13.4%
-10.4%
-$17M
—
$10M
Jun '23
$2M
-$20M
0.0%
0.0%
-12.2%
-9.8%
-$16M
—
$17M
Mar '23
$2M
-$23M
0.0%
0.0%
-12.3%
-9.4%
-$19M
—
$10M
Dec '22
$2M
-$22M
0.0%
0.0%
-17.6%
-10.3%
-$15M
$86M
$5M
Sep '22
$17M
$87M
0.0%
0.0%
61.3%
33.7%
-$25M
$82M
$9M
Jun '22
$3M
-$18M
0.0%
0.0%
-31.7%
-5.5%
-$9M
$199M
$44M
Mar '22
$6M
-$19M
0.0%
0.0%
-26.1%
-5.7%
-$20M
$201M
$40M
Dec '21
$4M
-$25M
0.0%
0.0%
-23.3%
-7.0%
-$17M
$180M
$36M
Sep '21
$3M
-$30M
0.0%
0.0%
-22.7%
-7.9%
-$19M
$180M
$42M
Valuation over time
How the market has priced PGEN against its own fundamentals since 2023-03 —
each month-end's share price set against the most recent annual filing, so the multiple moves
as price runs ahead of (or behind) earnings. Split-adjusted.
The price-to-earnings ratio has risen from 13.3× (Mar '23) to 17.0× (Dec '23).
The price-to-sales ratio has risen from 14.0× (Mar '23) to 263.8× (Sep '26).
Price / earnings (P/E)
P/E
Price / sales (P/S)
P/S
Frequently asked questions
Is PGEN growing its revenue and profit?
Over the past 5 years, Precigen, Inc.'s revenue has declined 21.3% per year. These are computed facts, not advice.
How much debt does PGEN have?
As of FY2025, Precigen, Inc. reported $93M of total debt against $30M of cash; operating income covered interest expense -28.6×.
What is PGEN's profit margin?
In FY2025, gross margin was —, operating margin -1141.1%, and net margin -2587.8%.
What is PGEN's P/E ratio?
As of Sep '26, Precigen, Inc. traded at a price-to-earnings ratio of about 17.0× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S have moved with the share price. These are computed facts, not advice.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted ·
growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price
against the latest annual filing. Informational only — not investment advice.